Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C.

Journal of Korean medical science - 1 Sept 2016

Kim Mi Na, Kim Hyon Suk, Kim Ja Kyung, Kim Beom Kyung, Kim Seung Up, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Han Kwang Hyub

Abstract excerpt

Hepatitis C virus core antigen (HCV Ag) is a recently developed marker of hepatitis C virus (HCV) infection. We investigated the clinical utility of the new HCV Ag assay for prediction of treatment response in HCV infection. We analyzed serum from 92 patients with HCV infection who had been treated with pegylated interferon and ribavirin. HCV Ag levels were determined at baseline in all enrolled patients and at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral
Share to Automation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoassay

Share to Interferon-alpha

Share to Polyethylene Glycols

Share to Reagent Kits, Diagnostic

Share to Recurrence

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 27510387
DOI: 10.3346/jkms.2016.31.9.1431
PMCID: PMC4974185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C.PMID 27510387Read ↗

New Automated Hepatitis C Virus (HCV) Core Antigen Assay as an Alternative to Real-Time PCR for HCV RNA QuantificationSemantic proximity Read ↗

Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.Semantic proximity Read ↗

Clinical utility of the ARCHITECT HCV Ag assay for early treatment monitoring in patients with chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Early predictive efficacy of core antigen on antiviral outcomes in genotype 1 hepatitis C virus infected patients.Semantic proximity Read ↗

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.Semantic proximity Read ↗

Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype.Semantic proximity Read ↗

Early decline of the HCV core antigen can predict SVR in patients with HCV treated by Pegylated interferon plus ribavirin combination therapy.Semantic proximity Read ↗

Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection.Semantic proximity Read ↗

The clinical significance of HCV core antigen detection during Telaprevir/Peg-Interferon/Ribavirin therapy in patients with HCV 1 genotype infection.Semantic proximity Read ↗

Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy.Semantic proximity Read ↗

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon alpha-2b plus ribavirin.Semantic proximity Read ↗

Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.